This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Angilique C Perkins: Innovator in CCR5 Antagonists
Introduction
Angilique C Perkins is a notable inventor based in Durham, NC (US). She has made significant contributions to the field of therapeutic agents, particularly in the treatment of CCR5-related diseases. Her work is crucial in the fight against HIV and AIDS.
Latest Patents
Angilique holds a patent for "CCR5 antagonists as therapeutic agents." This invention relates to compounds that are useful in the treatment and prophylaxis of CCR5-related diseases and disorders. Specifically, it focuses on inhibiting HIV replication and preventing or treating HIV infection, as well as addressing the resulting acquired immune deficiency syndrome (AIDS). She has 1 patent to her name.
Career Highlights
Angilique is currently associated with Smithkline Beecham Corporation, where she continues to advance her research and innovations. Her work has positioned her as a key player in the pharmaceutical industry, particularly in the development of treatments for viral infections.
Collaborations
Throughout her career, Angilique has collaborated with esteemed colleagues, including Wieslaw Mieczyslaw Kazmierski and Christopher Joseph Aquino. These partnerships have enhanced her research and contributed to the success of her projects.
Conclusion
Angilique C Perkins is a pioneering inventor whose work in CCR5 antagonists has the potential to change the landscape of HIV treatment. Her contributions are invaluable in the ongoing battle against this global health issue.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile